EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Molecular Basis of 5α-Reductase Type 2 Deficiency

Rafael L Batista, Berenice B Mendonca

Sexual Development · 2022 · 16 (2-3) · 171-183

DOI: 10.1159/000525119 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Sexual Development, online erschienen am 06.07.2022. Verfasst von Rafael L Batista und 1 weiteren Autor:innen. Beteiligte Einrichtung: Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Disciplina de Endocrinologi…. Hauptthemen laut MEDLINE: Disorder of Sex Development, 46,XY, Steroid Metabolism, Inborn Errors, Hypospadias. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 5α-reductase type 2 enzyme catalyzes the conversion of testosterone into dihydrotestosterone, playing a crucial role in male development. This enzyme is encoded by the SRD5A2 gene, which maps to chromosome 2 (2p23), consists of 5 exons and 4 introns, and encodes a 254 amino acid protein. Disruptions in this gene are the molecular etiology of a subgroup of differences of sex development (DSD) in 46,XY patients. Affected individuals present a large range of external genitalia undervirilization, ranging from almost typically female external genitalia to predominantly typically male external genitalia with minimal undervirilization, including isolated micropenis. This is an updated review of the implication of the SRD5A2 gene in 5α-reductase type 2 enzyme deficiency. For that, we identified 451 cases from 48 countries of this particular 46,XY DSD from the literature with reported variants in the SRD5A2 gene. Herein, we present the SRD5A2 mutational profile, the SRD5A2 polymorphisms, and the functional studies related to SRD5A2 variants to detail the molecular etiology of this condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disorder of Sex Development, 46,XYSteroid Metabolism, Inborn ErrorsHypospadiasHumansMaleFemale3-Oxo-5-alpha-Steroid 4-DehydrogenaseDihydrotestosteroneMutationMembrane Proteins

Stichwörter der Autor:innen

46,XY DSD5α-Reductase type 2 deficiencyAtypical genitaliaDifferences of sexual developmentDihydrotestosteroneDisorders of sexual developmentSRD5A2

Substanzen

3-Oxo-5-alpha-Steroid 4-DehydrogenaseDihydrotestosteroneSRD5A2 protein, humanMembrane Proteins

Autor:innen und Institutionen

  • Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Disciplina de Endocrinologia, do Departamento de Clínica Médica, Faculdade de Medicina da Univers…
  • Endocrine Oncology Unit, Instituto do Câncer do Estado de São Paulo, ICESP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Zitieren

APA

Batista, R. L., & Mendonca, B. B. (2022). The Molecular Basis of 5α-Reductase Type 2 Deficiency. Sexual Development, 16(2-3), 171-183. https://doi.org/10.1159/000525119

Vancouver

Batista RL, Mendonca BB. The Molecular Basis of 5α-Reductase Type 2 Deficiency. Sexual Development. 2022;16(2-3):171-183. doi:10.1159/000525119

BibTeX
@article{Batista2022,
  author = {Batista, Rafael L and Mendonca, Berenice B},
  title = {The Molecular Basis of 5α-Reductase Type 2 Deficiency},
  journal = {Sexual Development},
  year = {2022},
  volume = {16},
  number = {2-3},
  pages = {171--183},
  doi = {10.1159/000525119}
}
Kostenlos starten →